EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Convergence of Nanoscience and Stem Cells: A New Era in Cancer Therapeutics

Akshaya Priya Raveendran iD, Ragavendran G, Reya Rene Philip, Senbagam Duraisamy, Sankari D iD, Weslen Vedakumari Sathyaraj

Biotechnology Journal · 2026

DOI: 10.1002/biot.70188 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Akshaya Priya Raveendran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Chengalpattu, India. Hauptthemen laut MEDLINE: Neoplasms, Nanotechnology, Stem Cells, Stem Cell Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 106 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains one of the leading causes of global mortality, yet its treatment is frequently limited by poor drug distribution, systemic toxicity, and therapeutic resistance. Stem cells with their self‐renewal capacity, lineage‐specific differentiation, and intrinsic tumor‐homing ability have attracted considerable attention as potential mediators of targeted cancer therapy. Concurrently, nanotechnology offers tunable physicochemical properties and advanced tissue penetration, providing versatile platforms for drug delivery, imaging, and diagnostics. The convergence of nanotechnology and stem cell biology has expanded the therapeutic landscape, enabling multifunctional strategies for targeted drug delivery, imaging, and diagnostics. This review examines the challenges of drug delivery in oncology, elucidates the biological rationale for stem cell–mediated therapies, and explores the role of nanotechnology in augmenting their potential, emphasizing how the tumor‐homing capacity of stem cells can be exploited to overcome major barriers in conventional therapies. Furthermore, limitations, safety concerns, and the status of preclinical, and clinical development are discussed, with a focus on key research gaps and future directions to advance this interdisciplinary field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanotechnologyStem CellsStem Cell TransplantationHumansDrug Delivery SystemsAnimalsAntineoplastic Agents

Stichwörter der Autor:innen

cancer therapeuticsdrug deliverynanocarrierprecision medicinestem cell nanotechnology

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Chengalpattu, India.
  • Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, India.

ORCID-Profile: Akshaya Priya Raveendran, Sankari D

Zitieren

APA

Raveendran, A. P., G, R., Philip, R. R., Duraisamy, S., D, S., & Sathyaraj, W. V. (2026). The Convergence of Nanoscience and Stem Cells: A New Era in Cancer Therapeutics. Biotechnology Journal. https://doi.org/10.1002/biot.70188

Vancouver

Raveendran AP, G R, Philip RR, Duraisamy S, D S, Sathyaraj WV. The Convergence of Nanoscience and Stem Cells: A New Era in Cancer Therapeutics. Biotechnology Journal. 2026. doi:10.1002/biot.70188

BibTeX
@article{Raveendran2026,
  author = {Raveendran, Akshaya Priya and G, Ragavendran and Philip, Reya Rene and Duraisamy, Senbagam and D, Sankari and Sathyaraj, Weslen Vedakumari},
  title = {The Convergence of Nanoscience and Stem Cells: A New Era in Cancer Therapeutics},
  journal = {Biotechnology Journal},
  year = {2026},
  doi = {10.1002/biot.70188}
}
Kostenlos starten →